These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8638506)

  • 1. Management of hypertension, Part I.
    Moser M
    Am Fam Physician; 1996 May; 53(7):2295-302. PubMed ID: 8638506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertension management in general practice in Iceland].
    Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
    Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The need for evidence in hypertension management: historical perspective.
    Moawad MA
    Ann Saudi Med; 2005; 25(5):367-74. PubMed ID: 16270757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of hypertension in older persons.
    Dickerson LM; Gibson MV
    Am Fam Physician; 2005 Feb; 71(3):469-76. PubMed ID: 15712622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systolic-diastolic arterial hypertension versus isolated systolic hypertension].
    Giannuzzi P; Eleuteri E
    Ital Heart J; 2000 Jun; 1 Suppl 2():93-9. PubMed ID: 10905135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of white coat hypertension.
    Carek PJ; Carson DS; Cooke CE; Weart CW
    Am Fam Physician; 1995 Jul; 52(1):163-8. PubMed ID: 7604760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperlipidemia of diuretic therapy.
    Ames R
    Arch Mal Coeur Vaiss; 1998 Sep; 91 Suppl():23-7. PubMed ID: 9805566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Isolated systolic arterial hypertension in the elderly].
    Ivanović-Krstić B; Cvetković-Matić D; Nikcević Dj; Kalimanovska-Ostrić D; Avramović D
    Srp Arh Celok Lek; 1998; 126(3-4):125-9. PubMed ID: 9863368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of diuretics and beta-blockers in diabetic hypertensive patients. Results from a meta-analysis. The INDANA Steering Committee.
    Lièvre M; Gueyffier F; Ekbom T; Fagard R; Cutler J; Schron E; Marre M; Boissel JP
    Diabetes Care; 2000 Apr; 23 Suppl 2():B65-71. PubMed ID: 10860193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension treatment and the prevention of coronary heart disease in the elderly.
    Moser M
    Am Fam Physician; 1999 Mar; 59(5):1248-56. PubMed ID: 10088879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique dual mechanism of action of eprosartan: effects on systolic blood pressure, pulse pressure, risk of stroke and cognitive decline.
    Ram CV; Rudmann MA
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1003-11. PubMed ID: 18035916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New treatment guidelines for a patient with diabetes and hypertension.
    Mogensen CE
    J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.